Tom Farrel

Shares of Bellicum Pharmaceuticals Inc (NASDAQ: BLCM) were trading higher by 8 percent on Monday after the company announced that the U.S. Food and Drug Administration (FDA) granted its BPX-501 with an orphan drug designation. The FDA designation is for the combination of BPX-501 genetically...